NSE · MEDANTA
Global Health Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹1,079 Cr with net profit ₹137 Cr — a 12.73% net margin, versus 12.92% the period before.
Shareholding
As of 2026-06-30
- Promoter33%
- Public40.65%
- FII9.46%
- DII16.89%
1,40,531 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.62× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #6 of 85 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,26,078 Cr | 59.92 | 13.27 | 20.48% | 7.91% |
| Max Healthcare Institute Ltd. | ₹1,00,932 Cr | 67.43 | 9.36 | 13.42% | 16.73% |
| Manipal Health Enterpri Limited | ₹94,911 Cr | 101.2 | 5.78 | 10.59% | 7.81% |
| Fortis Healthcare Ltd. | ₹66,897 Cr | 62.71 | 6.77 | 10.53% | 11.02% |
| Aster DM Quality Care Ltd. | ₹66,465 Cr | 171.35 | 15.76 | 8.48% | 6.54% |
| Global Health Limited(this company) | ₹38,287 Cr | 66.89 | 9.66 | 14.05% | 11.88% |
| Narayana Hrudayalaya Ltd. | ₹38,187 Cr | 44.3 | 8.43 | 17.76% | 9% |
| Krishna Institute of Medical Sciences Ltd. | ₹33,258 Cr | 159.33 | 8.87 | 10.74% | 4.85% |
| Dr. Lal Path Labs Ltd. | ₹32,306 Cr | 57.44 | 12.89 | 20.13% | 18.75% |
| Poly Medicure Ltd. | ₹17,288 Cr | 54.02 | 5.59 | 10.37% | 15.77% |
AI analysis
AI-generated · google/gemini-2.5-flashGlobal Health Limited, operating under the symbol MEDANTA, has a market capitalization of Rs 35798 Cr. The company reported a revenue of Rs 4410.27 Cr with a profit margin of 12.62%. Its earnings per share (EPS) stands at Rs 20.73, and the stock is trading at a PE ratio of 248.4.
Positives
- +The company's revenue grew by 12.7%, indicating business expansion.
- +The debt-to-equity ratio is 0.24, suggesting a manageable debt level.
- +Promoter holding of 32.9992% is not pledged.
Negatives
- −The company's PE ratio is 248.4, which is high.
- −The promoter holding decreased from 33.0739% in June 2023 to 32.9992% in June 2026.
- −No quarterly results have been disclosed since March 2026.
Financial Performance
Global Health Limited recorded a revenue of Rs 4410.27 Cr, demonstrating a revenue growth of 12.7%. The net profit for the annual period ending March 2026 was Rs 556.46 Cr. For the quarter ending March 2026, the company's revenue was Rs 1159.05 Cr, with a net profit of Rs 143.99 Cr.
Profitability & Returns
The company’s profit margin is 12.62%. Return on equity (ROE) is 14.05%, and return on capital employed (ROCE) is 15.26%. The basic earnings per share (EPS) is Rs 20.73.
Balance Sheet
Global Health Limited has a book value per share of Rs 147.34. The debt-to-equity ratio is 0.24, indicating a modest level of debt relative to equity. The company does not currently offer a dividend, with a dividend yield of 0%.
Ownership & Pledges
Public shareholding stands at 40.6496%. There are no promoter shares pledged.
Regulatory & Surveillance
The company is not currently under any regulatory surveillance actions.
Data as of — price: 2026-09-18 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.